Full name
"APTEOPHARM" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.99.Z - Production of other products not classified elsewhere
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
73.11.Z - Advertising agency activities
73.12.C - Advertising through mass media
73.12.D - Advertising through mass media
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 3,2 | 1,5 | -52,6 | |
Gross profit (loss) | 2,5 | 3,2 | 2,3 | -26,2 |
EBITDA | 2,6 | 3,2 | 2,4 | -24,6 |
Short time liabilities | 2,6 | 3,2 | 4 | 24,3 |
Other operating costs | 0,1 | 0,1 | 25 | |
Equity capital | 2,2 | 3 | 2,4 | -20,8 |
Operating profit (EBIT) | 2,5 | 3,2 | 2,3 | -26 |
Assets | 4,9 | 6,3 | 6,5 | 4,2 |
Net profit (loss) | 2,1 | 2,6 | 1,9 | -26 |
Cash | 1,4 | 2,3 | 0,9 | -60,4 |
Net income from sale | 28,7 | 34,3 | 35,7 | 4 |
Liabilities and provisions for liabilities | 2,7 | 3,2 | 4,1 | 27,6 |
Working assets | 4,7 | 6,1 | 6,4 | 4,9 |
Other income costs | 0 | 0,9 | 2897 | |
Depreciation | 0,1 | 0,1 | 0,1 | 61,4 |
% | % | % | p.p. | |
Profitability of capital | 98,6 | 84,7 | 79,1 | -5,6 |
Equity capital to total assets | 44,3 | 48,3 | 36,7 | -11,6 |
Gross profit margin | 8,9 | 9,2 | 6,6 | -2,6 |
EBITDA Margin | 9,2 | 9,3 | 6,8 | -2,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 33 | 34 | 41 | 7 |
Current financial liquidity indicator | 1.8976480960845947 | 1.6016027927398682 | -0,3 | |
Net dept to EBITDA | -0.6787242293357849 | -0.3746916949748993 | 0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane